ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

DePinho Seeks New Review of Incubator Proposal

June 1, 2012

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990

NCI contract Awards; RFPs Available; RFAs, PA Available.

October 14, 1994

Broder, Herberman, Decline To Coauthor Reanalysis of Data

September 9, 1994

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986